Adlai Nortye (ANL) Payables (2022 - 2025)
Adlai Nortye's (ANL) quarterly Payables came in at $37.2 million in Q4 2025, up 2.04% year-on-year from $36.5 million in Q4 2024, and down 30.73% on a QoQ basis from $53.7 million in Q2 2025.
Adlai Nortye (ANL) Payables (2022 - 2025) Analysis & Trends
Adlai Nortye (ANL) has 4 years of Payables data on file, last reported at $37.2 million in Q4 2025.
- On a quarterly basis, Payables rose 2.04% year-over-year to $37.2 million in Q4 2025; TTM through Dec 2025 was $37.2 million, a 2.04% increase from a year earlier, with the FY2025 full-year figure at $37.2 million, up 2.04% from the prior year.
- Payables for Q4 2025 stood at $37.2 million, down from $53.7 million in the prior quarter.
- Over the last five years, Payables for ANL reached as high as $53.7 million in Q2 2025 and fell as low as $17.4 million in Q4 2022.
- Historically, Payables has averaged $39.9 million across 4 years, with a median of $41.0 million in 2023.
- Across the five-year window, Payables jumped 156.85% in 2023 and declined 18.41% in 2024, its largest moves.
- Year by year, Payables stood at $17.4 million in 2022, then soared by 156.85% to $44.7 million in 2023, then fell by 18.41% to $36.5 million in 2024, then advanced by 2.04% to $37.2 million in 2025.
- Per Business Quant data, the three most recent Payables figures were $37.2 million in Q4 2025, $53.7 million in Q2 2025, and $36.5 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 8.69 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 80.54 Mn |
| 10 | Adlai Nortye | 1.16 Bn | 1.15 Bn | - | 37.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.22 Mn |
| Jun 30, 2025 | 53.73 Mn |
| Dec 31, 2024 | 36.48 Mn |
| Jun 30, 2024 | 49.89 Mn |
| Dec 31, 2023 | 44.71 Mn |
| Dec 31, 2022 | 17.41 Mn |